Childhood pneumonia in developing countries

British Medical Journal

Volumn 333, Issue 7569, 2006, Pages 612-613

  Bhutta, Zulfiqar A ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIINFECTIVE AGENT; COTRIMOXAZOLE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; CHILDHOOD DISEASE; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; EDITORIAL; HEALTH CARE ACCESS; HEALTH CARE PERSONNEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPOXIA; INCIDENCE; INFECTION CONTROL; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PULSE OXIMETRY; RISK FACTOR; THORAX RADIOGRAPHY;

CHILD; DEVELOPING COUNTRIES; HUMANS; PNEUMONIA;

EID: 33748993424     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38975.602836.BE     Document Type: Editorial

References (13)

1. Bryce J, Boschi-Pinto C, Shibuya K, Black RE for the WHO Child Health Epidemiology Reference Group. WHO estimates of the causes of death in children. Lancet 2005;365:1147-52.
2. Rudan I, Tomaskovic L, Boschi-Pinto C, Campbell H for the WHO Child Health Epidemiology Reference Group. Global estimate of the incidence of clinical pneumonia among children under five years of age. Bull World Health Organ 2004;82:895-903.
3. Williams BG, Gouws E, Boschi-Pinto C, Bryce J, Dye C. Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis 2002;2:25-32.
4. Hazir T, Bin Nisar Y, Qazi SA, Khan SF, Raza M, Zameer S, et al. Chest radiography in children aged 2-59 months diagnosed with non-severe pneumonia as defined by the World Health Organization: descriptive multicentre study in Pakistan. BMJ 2006; doi: 10.1136/bmj.38915.673322.80
5. Nizami SQ, Bhutta ZA, Hasan R, Husen YA. Role of chest X-ray in the diagnosis of lower respiratory tract infections in children less than five years of age in community. Pak J Med Sci 2005;21:471-21.
6. World Health Organization. Antibiotics in the treatment of acute respiratory infections in young children. Geneva: WHO, 1990. (WHO/ARI/90.10.)
7. Klugman KP, Lonks JR. Hidden epidemic of macrolide resistant pneumococci. Emerg Infect Dis 2005;11:802-7.
8. Qazi S. Short-course therapy for community-acquired pneumonia in paediatric patients. Drugs 2005;65:1179-92.
9. Peltola H, Vuori-Holopainen E, Kallio MJ, for the SE-TU Study Group. Successful shortening from seven to four days of parenteral beta-lactam treatment for common childhood infections: a prospective and randomized study. Int J Infect Dis 2001;5:3-8.
10. Sazawal S, Black RE, for the Pneumonia Case Management Trials Group. Effect of pneumonia case management on mortality in neonates, infants, and preschool children: a meta-analysis of community-based trials. Lancet Infect Dis 2003;3:547-56.
11. United Nations Children's Fund, World Health Organization. WHO UNICEF joint statement. Management of pneumonia in community settings. Geneva: WHO, 2004. (WHO/FCH/CAH/04.06.)
12. Rasmussen ZA, Bari A, Qazi S, Rehman G, Azam I, Khan S, et al. Randomized controlled trial of standard versus double dose cotrimoxazole for childhood pneumonia in Pakistan. Bull World Health Organ 2005;83:10-9.
13. Jeena P, Thea DM, MacLeod WB, Chisaka N, Fox MP, Coovadia HM, et al. Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia. Bull World Health Organ 2006;84:269-75.